Skip to NavigationSkip to content

Diagnosis at stages 1-3 increases cancer survival rate significantly

Published on 25/01/19 at 09:46am

Adults diagnosed with stage 1 skin, prostate or breast cancer have the same chance of still being alive the following year as the average person, according to data from the Office for National Statistics and Public Health England.

Survival rates are high for many cancers if diagnosed in stages 1-3, the data shows. However cancers diagnosed in stage four have lower survival rates. Pancreatic cancer has the lowest rate of survival in both men and women.

Significantly, 90% of women diagnosed with breast cancer will survive for a year, if they are diagnosed at stages 1-3. However survival rates drop to 66%, when women are diagnosed at stage 4.

Meanwhile nearly 100% of men  diagnosed with prostate cancer at stages 1-3 survive compared to 87.6% of those diagnosed at stage 4.

Skin cancer was found to have the highest one year survival rate at stages 1-4 with 97.4% of men and 98.6% of women surviving for a year.

Sarah Caul, head of cancer analysis at the ONS, commented: “This research shows a mixed picture but does stress the need for awareness and early diagnosis.”

Overall cancer survival rates have been increasingly steadily in England since 2006.

Louis Goss

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches